Centese
Omaha, US · Delaware corporation · 4 known investors
Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions. The system is aimed at clinicians and ICU/critical care teams to support post-operative patient monitoring and recovery.
Founders & leadership
EL
Evan LuxonFounder
RP
Randy PrestonCEO
AC
Alan CheslerNamed on SEC filing
DB
Dan BurnettNamed on SEC filing
Board
RC
Radu CautisBoard director
DB
Daniel BurnettBoard director
DG
Deepak GangaharBoard director
Investors · 4
Competitors · 2
by search overlapTeleflex14 shared keywordsTeleflex is a medical device company. The available page content only references its receipt of an employer award for supporting veterans and does not describe its products or customers in detail.
Merit Medical12 shared keywordsMerit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
Companies competing with Centese for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$15.9M disclosed across 3 rounds · 2023–2026
▶$250KraisedMay 2026 · 1 investors · OtherRule 506(b)
▶$250KraisedMay 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Randy PrestonExecutive Officer, Director
- Daniel BurnettDirector
- Deepak GangaharDirector
- Radu CautisDirector
- Offering amount
- $5M
- Amount sold
- $250K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$525KraisedMay 2025 · 5 investors · Other Health CareRule 506(b)
▶$525KraisedMay 2025 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Evan LuxonExecutive Officer, Director
- Radu CautisDirector
- Daniel BurnettDirector
- Deepak GangaharDirector
- Offering amount
- $6.5M
- Amount sold
- $525K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.1MraisedNov 2023 · 50 investors · Other Health CareRule 506(b)
▶$15.1MraisedNov 2023 · 50 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alan CheslerDirector
- Dan BurnettDirector
- Deepak GangaharDirector
- Radu CautisDirector
- Evan LuxonExecutive Officer, Director
- Offering amount
- $23.1M
- Amount sold
- $15.1M
- Minimum investment
- $1
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Centese do?
- Centese develops Thoraguard, a digital surgical drainage system for cardiothoracic surgery that automates chest tube clog clearance and measures air leak rate and drainage volume, alerting care teams to disruptions. The system is aimed at clinicians and ICU/critical care teams to support post-operative patient monitoring and recovery.
- Who founded Centese?
- Centese was founded by Evan Luxon.
- Who are Centese's investors?
- Centese's investors include Invest Nebraska, New York Angels, Scientific Health Development, Medical Technology Venture Partners.
- How much funding has Centese raised?
- Centese has disclosed $15.9M raised across 3 rounds.
- Where is Centese headquartered?
- Centese is headquartered in Omaha, US.